Ullet index:NANO MRNA Co., Ltd.:4571

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index NANO MRNA Co., Ltd. Go to web site 4571 Medicals 東証グロース March 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

NANO MRNA Co., Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 2,740
plusdown
3,421
plusdown
4,253
plusdown
5,567
plusdown
7,500
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -835
plusdown
-780
plusup
-1,311
plusup
-1,882
plusup
-2,836
plus
Operating Cash Flow(OFC)Help -402
plusup
-585
plusup
-1,055
plusup
-1,753
plusdown
-1,200
plus
Free Cash Flow(FCF)Help 186
plusdown
208
plusup
153
plusup
-1,997
plusup
-2,072
plus
OFC - Net IncomeHelp 72
plusdown
82
plusup
79
plusdown
84
plusdown
88
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -16.98%
plusdown
-14.92%
plusup
-24.84%
plusup
-29.79%
plusdown
-18.24%
plus
Current Assets / Amount of SalesHelp 2,179.03%
plusdown
2,893.63%
plusup
2,100.41%
plusdown
2,228.79%
plusup
2,100.84%
plus
Free Cash Revenue RatioHelp 171.32%
plusup
153.44%
plusup
75.70%
plusup
-756.40%
plusdown
-661.43%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

NANO MRNA Co., Ltd.

Company where related level is highHelp

KISSEI PHARMACEUTICAL CO.,LTD.
Delta-Fly Pharma,Inc.
Toyama Chemical Co.,Ltd.
NANO MRNA Co., Ltd.
MUROMACHI CHEMICALS INC.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
Kubota Pharmaceutical Holdings Co.,Ltd.
Astellas Pharma Inc.
KYORIN Pharmaceutical Co., Ltd.